IFE is an independent international research foundation for energy and nuclear technology. IFE’s mandate is to undertake research and development, on an ideal basis and for the benefit of society, within renewable energy and environmental technology, oil and gas, nuclear medicine and nuclear safety, and to carry out assignments in the field of nuclear technology for the nation.
Every year one to two percent of Norway’s population undergoes a medical assessment using radioactive pharmaceutical products. The isotope laboratories at IFE are the Norwegian control organ for radioactive medicines. The laboratories are organized as a pharmacy and provide advice and guidance on the use of the products. The majority of radioactive medicines used in Norway are controlled at IFE before they are sent out to Norwegian hospitals.
The isotope Laboratories at IFE has significant expertise and know-how across the entire product development chain supported by experienced staff in radiochemistry and radiopharmacy.
They have dedicated laboratories for production, packaging and quality control of radiopharmaceuticals. These laboratories are classified in respect of cleanliness classes in accordance with international GMP (Good Manufacturing Practice) rules and in accordance with radiation protection legislation.